Background Biological therapy is currently widely used to treat IBD. Infliximab, adalimumab
and golimumab are currently licensed anti‐TNF therapies. Biosimilar anti‐TNF monoclonal …

The link between cytomegalovirus (CMV) infection and inflammatory bowel diseases
remains an important subject of debate. CMV infection is frequent in ulcerative colitis (UC) …

Methods: These guidelines are a joint effort of the European Crohn's and Colitis
Organization (ECCO) and the European Society of Paediatric Gastroenterology, Hepatology …

Cytomegalovirus (CMV) infects approximately 40% of adults in France and persists lifelong
as a latent agent in different organs, including gut. A close relationship is observed between …

Background The role of antiviral therapy in patients with ulcerative colitis (UC) with
cytomegalovirus (CMV) remains unclear. We therefore performed a systematic review and …

Background Cytomegalovirus (CMV) is frequently detected in patients with ulcerative colitis
(UC). The impact of CMV infection on the outcome of UC exacerbation remains unclear. The …

AIM: To evaluate the impact of antiviral treatment on cytomegalovirus (CMV)-positive
ulcerative colitis patients. METHODS: We performed a systematic review and meta-analysis …

Objective The role of cytomegalovirus (CMV) reactivation in the outcome of inflammatory
bowel diseases (IBDs) is unclear. Uncertainties remain on the treatment of CMV infection …

Background: Data on the clinical course and outcomes of pediatric patients with
cytomegalovirus (CMV) infection complicating acute severe ulcerative colitis (ASC) are very …

Background and purpose Anti-TNFα agents emerged in inflammatory bowel disease (IBD)
as an effective option in situations that, otherwise, would be refractory to medical therapy …